ASX:CLL Collerina Cobalt (CLL) Stock Price, News & Analysis → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free CLL Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume1,000 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Collerina Cobalt alerts: Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About Collerina Cobalt Stock (ASX:CLL)Collerina Cobalt Limited engages in the acquisition, exploration, and development of mineral deposits in Australia and Indonesia. The company explores for gold, copper, nickel, and cobalt. It holds interest in the Collerina project covering an area of 150 square kilometers located to the south of Nyngan in central New South Wales; and the Wonogiri project covering an area of approximately 3,928 hectares located in central Java, Indonesia. The company was formerly known as Augur Resources Ltd and changed its name to Collerina Cobalt Limited in May 2017. Collerina Cobalt Limited is headquartered in Sydney, Australia.Read More Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> CLL Stock News HeadlinesApril 8, 2023 | abcnews.go.comDoctors say former Italian Premier Silvio Berlsconi is being treated for a lung infection and has long had leukemiaFebruary 27, 2023 | forbes.comBest Business Cell Phone Plans Of 2023April 26, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.February 26, 2023 | marketwatch.comCobalt Hydroxide Market Size in 2023 SHARE, TRENDS till 2026February 19, 2023 | benzinga.comChronic Lymphocytic Leukemia (CLL) Global Market Report 2023: Featuring BMS, Autolus Therapeutics & Sian Wuhan Medical TechnologyOctober 16, 2022 | washingtonpost.comHave you exercised your body fat lately?See More Headlines Receive CLL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Collerina Cobalt and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/16/2018Today4/26/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorBasic Materials Industry Copper Sub-IndustryN/A Current SymbolASX:CLL CUSIPN/A CIKN/A Webwww.augur.com.au Phone+61-2-93003310FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares567,100,032Free FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesMr. Rimas KairaitisMD & DirectorMr. Peter James Nightingale B.Econ (Age 61)CA, CFO & Director Mr. Michael CoreyHead of ExplorationMr. Richard James Edwards BComCPA, SA Fin, FGIA, Company Sec.Key CompetitorsAlma MetalsASX:ALMAntofagastaOTCMKTS:ANFGFArizona Sonoran CopperOTC:ASCUFAustral Resources AustraliaASX:AR1Capstone CopperOTCMKTS:CSCCFView All Competitors CLL Stock Analysis - Frequently Asked Questions How were Collerina Cobalt's earnings last quarter? Collerina Cobalt Limited (ASX:CLL) issued its quarterly earnings data on Friday, March, 16th. The company reported $0.00 earnings per share (EPS) for the quarter. This page (ASX:CLL) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchJeff Bezos Just Humiliated Elon MuskInvestorPlaceBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Collerina Cobalt Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
